查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571826

疟疾诊断市场规模、份额、趋势分析报告：按技术、最终用途、地区、细分市场预测，2024-2030 年

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microscopy, Rapid Diagnostic Tests), By End Use (Clinics, Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

疟疾诊断市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，2024 年至 2030 年，全球疟疾诊断市场规模预计将以 2.6% 的复合年增长率增长，到 2030 年将达到 9.005 亿美元。

流行国家热带疾病盛行率的增加、新型诊断技术的市场开拓以及地区政府和私人投资者投资的增加预计将推动市场成长。疟疾是最普遍、威胁生命的疾病，由于气候变迁、经济成长缓慢、医疗基础设施不发达以及缺乏先进治疗方法，常见于热带和亚热带地区。

政府措施和市场参与企业增加的投资预计也将在不久的将来推动市场成长。在 COVID-19 大流行期间，非洲地区可用的抗疟治疗方案非常丰富，可用于控制和遏制感染的传播。在 COVID-19 大流行期间，除了 COVID-19 病毒外，疟疾病例持续增加，市场受到重大提振。

大公司正在实施许多消灭疟疾计划，以遏止这种疾病的传播。例如，诺华公司的疟疾计画旨在加速消除和控制疟疾。该公司与各种组织一起为 60 个国家的 7.5 亿人提供了非营利性护理。希望这些努力能鼓励新技术的开拓并有助于市场渗透。

疟疾诊断市场报告亮点

  • 显微镜传统上用于检测疟疾原虫，是显微镜技术领域的领导者。
  • 由于易于使用、方便和快速诊断，RDT 预计将占据最大的销售份额。
  • 由于其准确性和检测低寄生虫数量的能力，分子诊断测试领域预计将成为预测期内成长最快的技术领域。
  • 由于疟疾盛行率高以及各种疟疾诊断技术的采用不断增加，非洲将在 2023 年引领市场。
  • 由于疾病频繁復发以及遏制疟疾流行的努力，东南亚预计将以 2.3% 的复合年增长率增长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章疟疾诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 疟疾诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章疟疾诊断市场：技术评估与趋势分析

  • 技术市场占有率，2023/2030
  • 细分仪表板
  • 全球疟疾诊断市场：按技术展望
  • 2018-2030年市场规模/预测与趋势分析

第五章疟疾诊断市场：最终用途估计与趋势分析

  • 2023年及2030年市场占有率方法
  • 细分仪表板
  • 全球疟疾诊断市场展望：依最终用途分类
  • 2018-2030年市场规模/预测与趋势分析

第六章疟疾诊断市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模、预测趋势分析：
  • 非洲
    • 奈及利亚
    • 刚果民主共和国
    • 坦尚尼亚联合共和国
    • 乌干达
    • 南非
    • 莫三比克
    • 安哥拉
    • 迦纳
    • 波札那
    • 纳米比亚
  • 东南亚
    • 印度
    • 缅甸
    • 印尼
  • 东地中海
    • 沙乌地阿拉伯
    • 巴基斯坦
  • 西太平洋
    • 中国
    • 巴布亚纽几内亚
    • 柬埔寨
  • 美洲
    • 委内瑞拉
    • 巴西
    • 哥伦比亚
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 土耳其

第七章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Access Bio, Inc.
    • Abbott Laboratories
    • Premier Medical Corporation Pvt. Ltd.
    • Sysmex Partec GmbH
    • Siemens Healthineers
    • bioMerieux
    • Beckman Coulter, Inc.
    • Leica Microsystems GmbH
    • Bio-Rad Laboratories, Inc.
Product Code: 978-1-68038-711-7

Malaria Diagnostics Market Growth & Trends:

The global malaria diagnostics market size is projected to reach USD 900.5 million by 2030, expanding at a CAGR of 2.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.

A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Malaria Diagnostics Market Report Highlights:

  • Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
  • RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis.
  • The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count.
  • Africa led the market in 2023 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region.
  • Southeast Asia is expected to grow at a CAGR of 2.3% owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Malaria Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
      • 3.2.1.2. Development of technologically advanced and efficient diagnostics
      • 3.2.1.3. Market players and private investors to curb the prevalence of malaria
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Increasing number of countries in the malaria elimination phase
      • 3.2.2.2. Demand for low-cost malaria diagnostic tests
  • 3.3. Malaria Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Malaria Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Malaria Diagnostics Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Molecular Diagnostic Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Conventional PCR
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Modernized PCR
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Microscopy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Rapid Diagnostic Tests (RDT)

Chapter 5. Malaria Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Method Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Malaria Diagnostics Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals & Clinics
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diagnostic Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Academic and Research Institutes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Malaria Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. Africa
    • 6.5.1. Nigeria
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Democratic Republic of the Congo
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. United Republic of Tanzania
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Uganda
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Africa
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Mozambique
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Angola
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Ghana
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.9. Botswana
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework/ reimbursement structure
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.10. Namibia
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework/ reimbursement structure
      • 6.5.10.3. Competitive scenario
      • 6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. South East Asia
    • 6.6.1. India
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Myanmar
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Indonesia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Eastern Mediterranean
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Pakistan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Western Pacific
    • 6.8.1. China
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Papua New Guinea
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Cambodia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Americas
    • 6.9.1. Venezuela
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Brazil
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. Colombia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Europe
    • 6.10.1. UK
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Regulatory framework/ reimbursement structure
      • 6.10.1.3. Competitive scenario
      • 6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.2. Germany
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Regulatory framework/ reimbursement structure
      • 6.10.2.3. Competitive scenario
      • 6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.3. France
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Regulatory framework/ reimbursement structure
      • 6.10.3.3. Competitive scenario
      • 6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.4. Turkey
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Regulatory framework/ reimbursement structure
      • 6.10.4.3. Competitive scenario
      • 6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Access Bio, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Premier Medical Corporation Pvt. Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Sysmex Partec GmbH
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Siemens Healthineers
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. bioMerieux
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Beckman Coulter, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Leica Microsystems GmbH
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Bio-Rad Laboratories, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Africa malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 3 Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Nigeria malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Nigeria malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Democratic Republic of Congo malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Democratic Republic of Congo malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Uganda malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Uganda malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 United Republic of Tanzania malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 United Republic of Tanzania malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 13 South Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 South Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mozambique malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Mozambique malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Angola malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Angola malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Ghana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Ghana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Botswana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Botswana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Namibia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Namibia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 South East Asia malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 26 South East Asia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 South East Asia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 India malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 29 India malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Myanmar malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Myanmar malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Indonesia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Indonesia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Eastern Mediterranean malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 35 Eastern Mediterranean malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Eastern Mediterranean malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Saudi Arabia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Saudi Arabia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Pakistan malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Pakistan malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Western Pacific malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 42 Western Pacific malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Western Pacific malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 China malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Papua New Guinea malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Papua New Guinea malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Cambodia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Cambodia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Americas malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 51 Americas malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Americas malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Venezuela malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Venezuela malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Brazil malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Brazil malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Colombia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Colombia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Europe malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 60 Europe malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Europe malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Turkey malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Turkey malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64 France malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 France malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 UK malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 67 UK malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Germany malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Germany malaria diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in Africa
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in South East Asia
  • Fig. 7 Primary interviews in Eastern Mediterranean
  • Fig. 8 Primary interviews in Western Pacific
  • Fig. 9 Primary interviews in Americas
  • Fig. 10 Primary interviews in Europe
  • Fig. 11 Market research approaches
  • Fig. 12 Value-chain-based sizing & forecasting
  • Fig. 13 QFD modeling for market share assessment
  • Fig. 14 Market formulation & validation
  • Fig. 15 Malaria Diagnostics market: market outlook
  • Fig. 16 Malaria Diagnostics competitive insights
  • Fig. 17 Parent market outlook
  • Fig. 18 Related/ancillary market outlook
  • Fig. 19 Penetration and growth prospect mapping
  • Fig. 20 Industry value chain analysis
  • Fig. 21 Malaria Diagnostics market driver impact
  • Fig. 22 Malaria Diagnostics market restraint impact
  • Fig. 23 Malaria Diagnostics market strategic initiatives analysis
  • Fig. 24 Malaria Diagnostics market: Technology movement analysis
  • Fig. 25 Malaria Diagnostics market: Technology outlook and key takeaways
  • Fig. 26 Molecular Diagnostic Tests market estimates and forecasts, 2018 - 2030
  • Fig. 27 Conventional PCR market estimates and forecasts, 2018 - 2030
  • Fig. 28 Modernized PCR market estimates and forecasts, 2018 - 2030
  • Fig. 29 Microscopy market estimates and forecasts, 2018 - 2030
  • Fig. 30 Rapid Diagnostic Tests (RDT) market estimates and forecasts, 2018 - 2030
  • Fig. 31 Malaria Diagnostics market: End Use movement analysis
  • Fig. 32 Malaria Diagnostics market: End Use outlook and key takeaways
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2018 - 2030
  • Fig. 34 Diagnostic Centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Academic and Research Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global malaria diagnostics market: Regional movement analysis
  • Fig. 37 Global malaria diagnostics market: Regional outlook and key takeaways
  • Fig. 38 Global malaria diagnostics market share and leading players
  • Fig. 39 Africa market share and leading players
  • Fig. 40 Europe market share and leading players
  • Fig. 41 South East Asia market share and leading players
  • Fig. 42 Eastern Mediterranean market share and leading players
  • Fig. 43 Western Pacific market share and leading players
  • Fig. 44 Americas market share and leading players
  • Fig. 45 Africa market estimates and forecasts, 2018 - 2030
  • Fig. 46 Nigeria market estimates and forecasts, 2018 - 2030
  • Fig. 47 Democratic Republic of Congo market estimates and forecasts, 2018 - 2030
  • Fig. 48 Uganda market estimates and forecasts, 2018 - 2030
  • Fig. 49 United Republic of Tanzania market estimates and forecasts, 2018 - 2030
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mozambique market estimates and forecasts, 2018 - 2030
  • Fig. 52 Angola market estimates and forecasts, 2018 - 2030
  • Fig. 53 Ghana market estimates and forecasts, 2018 - 2030
  • Fig. 54 Botswana market estimates and forecasts, 2018 - 2030
  • Fig. 55 Namibia market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 59 France market estimates and forecasts, 2018 - 2030
  • Fig. 60 Turkey market estimates and forecasts, 2018 - 2030
  • Fig. 61 South East Asia market estimates and forecasts, 2018 - 2030
  • Fig. 62 India market estimates and forecasts, 2018 - 2030
  • Fig. 63 Myanmar market estimates and forecasts, 2018 - 2030
  • Fig. 64 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 65 Eastern Mediterranean market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 Pakistan market estimates and forecasts, 2018 - 2030
  • Fig. 68 Western Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 69 China market estimates and forecasts, 2018 - 2030
  • Fig. 70 Papua New Guinea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Cambodia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Americas market estimates and forecasts, 2018 - 2030
  • Fig. 73 Venezuela market estimates and forecasts, 2018 - 2030
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Malaria Diagnostics market